Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Harvard Bioscience (HBIO) Equity Income (2023 - 2024)

Historic Equity Income for Harvard Bioscience (HBIO) over the last 2 years, with Q2 2024 value amounting to -$281000.0.

  • Harvard Bioscience's Equity Income rose 8222.64% to -$281000.0 in Q2 2024 from the same period last year, while for Mar 2025 it was -$281000.0, marking a year-over-year increase of 8554.53%. This contributed to the annual value of -$1.6 million for FY2024, which is 15205.7% down from last year.
  • Latest data reveals that Harvard Bioscience reported Equity Income of -$281000.0 as of Q2 2024, which was up 8222.64% from -$1.3 million recorded in Q1 2024.
  • Harvard Bioscience's 5-year Equity Income high stood at $1.2 million for Q3 2023, and its period low was -$1.6 million during Q2 2023.